Innovative Clinical Research

Innovative Clinical Research (ICR) is a physician-led clinical research organization (CRO) and research site based in Clarksville, Tennessee. Founded by Dr. Mary Kosinski, Dr. Joseph Kosinski, and Dr. Bradley Vander Veen, the company specializes in Phase I-IV clinical trials across diverse therapeutic areas, including liver health (MASLD/MASH), metabolic diseases, obesity, and vaccines. ICR is dedicated to bringing advanced medical treatments and diagnostics, such as FibroScan technology, to local communities, bridging the gap between community medicine and academic research. The organization has a track record of contributing to the development of major medical breakthroughs, including Rezdiffra, Paxlovid, and the RSV vaccine.